Akums’ acquires new formulation facility in Baddi
It is slated to become operational in the year 2024
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Takeda signs MoU with BIRAC to support healthcare start-ups
Besides supporting healthcare startups, the partnership will also contribute to India’s aspiration of emerging as a $300 billion…
Lex Witness to host 9th Annual Pharma Legal & Compliance Summit 2023 in Mumbai
The summit is scheduled for December 8, 2023 at the Courtyard by Marriott, Mumbai, Andheri East
Industry and academia should work together to combine discovery biology and translational research
Prof Arun Kumar Shukla, Professor and Sonu Agrawal Memorial Chair, Biological Sciences and Bioengineering, Indian Institute of…
Non-stimulants face uphill battle to penetrate ADHD market despite lower abuse potential: GlobalData
A better alternative strategy to penetrate the saturated ADHD market would be to target key unmet needs in ADHD treatment such as…
AbbVie’s $10.1 bn Immunogen deal fortifies oncology portfolio, signals big pharma’s ADC…
Earlier this year, Pfizer acquired ADC giant Seagen for $43 billion in one of the largest M&A deals in industry history
Mumbai to host IDMA’s flagship event, Pharma Live Expo & Summit in Jan 2024
Set to host more than 500 exhibitors and showcase above 20,000 products
Syngene concludes acquisition of biologics facility from Stelis Biopharma
The acquisition of the ‘Unit 3’ biologics manufacturing facility was concluded at a revised gross value of Rs 617 crores adjusted…
Lupin launches Turqoz (Norgestrel and Ethinyl Estradiol) Tablets USP in the US
Turqoz Tablets USP 0.3 mg/0.03 mg is a contraceptive drug indicated to prevent pregnancy
We are committed to delivering excellence across the pharma supply chain
Rajesh Vedak, MD, Körber India speaks about his company's innovative solutions, strategies to maintain its technological…